Pharmacologically active CNS compounds
US5684005A · kind A · utility
4Cited by
10References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Nov 4, 1997 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of substituted phenylpyrimidine compounds are disclosed which are potent inhibitors of the excitatory amino acid, glutamate. Such compounds are useful in the treatment or prevention of a range of CNS disorders including cerebral ischaemic damage and epilepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.